Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Microbes and Other Elemental Cycles01:24

Microbes and Other Elemental Cycles

Microbial activity plays a pivotal role in the biogeochemical cycling of iron and manganese, especially at the redox gradients characteristic of stratified aquatic environments. These cycles are driven by microbial transformations between oxidized and reduced forms of the metals, allowing organisms to exploit them for metabolic energy and structural purposes.Iron Cycling Across Redox GradientsIn neutral, oxygen-rich surface waters, iron is predominantly found in its oxidized, insoluble ferric...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation of Mitochondria from Retinal Pigment Epithelial Cell Cultures and an Application of High-Resolution Respirometric Assay (XF<sup>e</sup>96 Seahorse Assay).

Methods in molecular biology (Clifton, N.J.)·2021
Same author

Ceramide Synthase 6 Maximizes p53 Function to Prevent Progeny Formation from Polyploid Giant Cancer Cells.

Cancers·2021
Same author

Newly Identified Chemicals Preserve Mitochondrial Capacity and Decelerate Loss of Photoreceptor Cells in Murine Retinal Degeneration Models.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2021
Same author

Mitochondrial C3a Receptor Activation in Oxidatively Stressed Epithelial Cells Reduces Mitochondrial Respiration and Metabolism.

Frontiers in immunology·2021
Same author

An improved method for isolation of mitochondria from cell lines that enables reconstitution of calcium-dependent processes.

Analytical biochemistry·2019
Same author

Small Molecules that Protect Mitochondrial Function from Metabolic Stress Decelerate Loss of Photoreceptor Cells in Murine Retinal Degeneration Models.

Advances in experimental medicine and biology·2015

Related Experiment Video

Updated: Jul 11, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

Targeting iron acquisition by Mycobacterium tuberculosis.

Ryan R Monfeli1, Craig Beeson

  • 1Department of Biomedical and Pharmaceutical Sciences, Medical University of South Carolina, Charleston, SC 29425, USA.

Infectious Disorders Drug Targets
|September 28, 2007
PubMed
Summary

Targeting iron acquisition in Mycobacterium tuberculosis offers new therapeutic strategies. Modulating the iron-dependent regulator protein (IdeR) shows promise for combating drug-resistant tuberculosis.

More Related Videos

Isolation and Characterization of Extracellular Vesicles Produced by Iron-limited Mycobacteria
08:27

Isolation and Characterization of Extracellular Vesicles Produced by Iron-limited Mycobacteria

Published on: October 31, 2019

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

Related Experiment Videos

Last Updated: Jul 11, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

Isolation and Characterization of Extracellular Vesicles Produced by Iron-limited Mycobacteria
08:27

Isolation and Characterization of Extracellular Vesicles Produced by Iron-limited Mycobacteria

Published on: October 31, 2019

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

Area of Science:

  • Microbiology
  • Drug Discovery
  • Biochemistry

Background:

  • Tuberculosis (TB) remains a significant global health challenge, exacerbated by multidrug-resistant strains.
  • Iron acquisition is crucial for Mycobacterium tuberculosis survival and virulence.
  • Host defense mechanisms, like siderocalins, sequester iron, hindering bacterial replication.

Purpose of the Study:

  • To explore novel therapeutic targets for tuberculosis, focusing on iron acquisition pathways.
  • To investigate the potential of targeting the iron-dependent regulator protein (IdeR) as an anti-tubercular strategy.

Main Methods:

  • Review of recent research on siderophore synthesis inhibitors and IdeR-targeting agents.
  • Analysis of structural insights into IdeR's iron activation and DNA binding.
  • Exploration of structure-based drug design approaches for IdeR modulation.

Main Results:

  • Siderophore analogues and enzyme inhibitors show potential against bacterial growth.
  • Targeting IdeR offers a distinct approach, modulating virulence through iron homeostasis.
  • Structure-based design enables the development of agents to modulate IdeR activity.

Conclusions:

  • Targeting iron acquisition, particularly IdeR, presents a promising avenue for developing new anti-tubercular drugs.
  • Modulating IdeR function through small peptides offers rational therapeutic strategies against Mycobacterium tuberculosis.